BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24447562)

  • 1. [Pathology of mammary mucinous carcinoma and its molecular markers].
    Zhang W; Niu Y; Zhang TX; Liu S; Liu F
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):777-9. PubMed ID: 24447562
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: Coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas.
    Adsay NV; Merati K; Nassar H; Shia J; Sarkar F; Pierson CR; Cheng JD; Visscher DW; Hruban RH; Klimstra DS
    Am J Surg Pathol; 2003 May; 27(5):571-8. PubMed ID: 12717243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous carcinoma of the breast: a multifaceted study with special reference to histogenesis and neuroendocrine differentiation.
    Kato N; Endo Y; Tamura G; Katayama Y; Motoyama T
    Pathol Int; 1999 Nov; 49(11):947-55. PubMed ID: 10594840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas.
    Karasaki H; Mizukami Y; Tokusashi Y; Koizumi K; Ishizaki A; Imai K; Yoshikawa D; Kino S; Sasajima J; Tanno S; Matsumoto K; Miyokawa N; Kono T; Kohgo Y; Furukawa H
    Pancreas; 2011 May; 40(4):588-94. PubMed ID: 21441843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of mammary carcinoma.
    Perez-Mesa CM
    Major Probl Clin Surg; 1967; 5():70-87. PubMed ID: 4351551
    [No Abstract]   [Full Text] [Related]  

  • 7. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion.
    Gadre SA; Perkins GH; Sahin AA; Sneige N; Deavers MT; Middleton LP
    Histopathology; 2008 Nov; 53(5):545-53. PubMed ID: 18983463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
    Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
    Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.
    Kim D; Jung WH; Koo JS
    Pathobiology; 2012; 79(3):144-53. PubMed ID: 22269464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous lesions of the breast. A pathological continuum.
    Weaver MG; Abdul-Karim FW; al-Kaisi N
    Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-positivity in mucinous cancer might be related to accompanying infiltrating ductal carcinoma histology.
    Altundag K
    Breast Cancer Res Treat; 2020 Apr; 180(3):829. PubMed ID: 32162191
    [No Abstract]   [Full Text] [Related]  

  • 12. The mucinous variant of columnar cell lesions.
    Verschuur-Maes AH; Van Diest PJ
    Histopathology; 2011 May; 58(6):847-53. PubMed ID: 21585423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between solid papillary carcinoma and associated invasive carcinoma according to expression of WT1 and several MUCs.
    Oh EJ; Koo JS; Kim JY; Jung WH
    Pathol Res Pract; 2014 Dec; 210(12):953-8. PubMed ID: 25204785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can mucinous lesions of the breast be reliably diagnosed by core needle biopsy?
    Renshaw AA
    Am J Clin Pathol; 2002 Jul; 118(1):82-4. PubMed ID: 12109860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma of the female breast. Morphological aspects].
    Silva JN
    Arq Patol; 1972 Aug; 43(2):109-20. PubMed ID: 4343609
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases.
    Ro JY; Sneige N; Sahin AA; Silva EG; del Junco GW; Ayala AG
    Arch Pathol Lab Med; 1991 Feb; 115(2):137-40. PubMed ID: 1847035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast neoplasms: histological classification].
    Sakamoto G
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
    [No Abstract]   [Full Text] [Related]  

  • 18. Precursor lesions of mucinous carcinoma of the breast: analysis of 130 cases.
    Kryvenko ON; Chitale DA; Yoon J; Arias-Stella J; Meier FA; Lee MW
    Am J Surg Pathol; 2013 Jul; 37(7):1076-84. PubMed ID: 23759933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.